| P2093 | author name string | Gregory M Lanza | |
| | Samuel A Wickline | |
| | Hua Pan | |
| | Kirk K Hou | |
| P2860 | cites work | Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 |
| | Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 |
| | Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells | Q41078793 |
| | The role of constitutively activated STAT3 in B16 melanoma cells | Q42434370 |
| | PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation | Q42787946 |
| | Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. | Q42800876 |
| | RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system | Q43192622 |
| | VEGF differentially activates STAT3 in microvascular endothelial cells | Q44489900 |
| | Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis | Q45165256 |
| | On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids. | Q45175352 |
| | Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency. | Q45960266 |
| | Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. | Q46802802 |
| | Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation | Q47745076 |
| | Effects of temperature and lipid composition on the serum albumin-induced aggregation and fusion of small unilamellar vesicles | Q58849852 |
| | Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism | Q77900470 |
| | Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation | Q83808450 |
| | Breaking down the barriers: siRNA delivery and endosome escape | Q83964547 |
| | Strategies and advances in nanomedicine for targeted siRNA delivery | Q84477460 |
| | Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics | Q30486235 |
| | Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect | Q33265007 |
| | Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. | Q33684461 |
| | Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors | Q33959754 |
| | Small molecule inhibitors of STAT3 for cancer therapy | Q33985265 |
| | Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents | Q34058557 |
| | Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12. | Q34243816 |
| | Delivery of siRNA therapeutics: barriers and carriers | Q34293708 |
| | Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling | Q34381627 |
| | Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. | Q34507158 |
| | Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo | Q35223878 |
| | Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailability | Q35595798 |
| | A CD36-dependent signaling cascade is necessary for macrophage foam cell formation | Q35758193 |
| | Delivery strategies for siRNA-mediated gene silencing | Q36446972 |
| | Toxicity of cationic lipids and cationic polymers in gene delivery | Q36532318 |
| | Postformulation peptide drug loading of nanostructures | Q36780035 |
| | Cell-penetrating-peptide-based delivery of oligonucleotides: an overview | Q36883965 |
| | Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides | Q37043911 |
| | Cell-penetrating peptides: from molecular mechanisms to therapeutics. | Q37110276 |
| | Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics | Q37230918 |
| | Nanovector delivery of siRNA for cancer therapy | Q37347097 |
| | Cellular delivery in vivo of siRNA-based therapeutics | Q37347442 |
| | Peptide-based nanoparticle for ex vivo and in vivo drug delivery | Q37347454 |
| | Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape | Q37453943 |
| | Chemically modified cell-penetrating peptides for the delivery of nucleic acids | Q37615342 |
| | Lipid-based nanotherapeutics for siRNA delivery | Q37670986 |
| | Endosomal escape pathways for delivery of biologicals | Q37809596 |
| | Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy | Q38037048 |
| | Formulation approaches to short interfering RNA and MicroRNA: challenges and implications. | Q38038550 |
| | Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain | Q38352651 |
| | Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides | Q39541959 |
| | Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells | Q39713266 |
| | Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. | Q39717127 |
| | Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. | Q40140417 |
| | Novel receptor-mediated gene delivery system comprising plasmid/protamine/sugar-containing polyanion ternary complex | Q40586680 |
| | Attenuation of green fluorescent protein half-life in mammalian cells | Q40909794 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 3110-3119 | |
| P577 | publication date | 2013-02-04 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Melittin derived peptides for nanoparticle based siRNA transfection | |
| P478 | volume | 34 | |